Trial of MRSA decolonisation treatment in adult hospital in-patients
- Conditions
- Methicillin-resistant Staphylococcus aureus (MRSA) positive colonisationInfections and Infestations
- Registration Number
- ISRCTN12184897
- Lead Sponsor
- South Tees Hospitals NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped
- Sex
- All
- Target Recruitment
- 32
1. Adult in-patient (aged 16 years old or over)
2. Eligible for MRSA screening on admission, based on the local hospital infection control policy, who are found to be colonised with MRSA
1. Known hypersensitivity to study treatment(s) or excipients
2. Allergy to peanut and/or soya
3. Day-case admissions
4. Patients identified to be colonised with MRSA in the outpatient setting
5. Previous participation in the TIDE trial or current participation in another trial of a medicinal product that does not allow co-enrolment
6. Patients actively undergoing another decolonisation treatment at the time of recruitment
7. Medical history that might, in the opinion of the attending clinician, put the patient at significant risk if they were to participate in the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Successful early nasal decolonisation, defined as a negative trial-specific nasal MRSA swab taken 48 hours following treatment completion
- Secondary Outcome Measures
Name Time Method